Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Tobacco dependence and withdrawal: science base, challenges and opportunities for pharmacotherapy.

Henningfield JE, Shiffman S, Ferguson SG, Gritz ER.

Pharmacol Ther. 2009 Jul;123(1):1-16. doi: 10.1016/j.pharmthera.2009.03.011. Epub 2009 Apr 8. Review.

2.

Efficacy and tolerability of pharmacotherapies to aid smoking cessation in adolescents.

Bailey SR, Crew EE, Riske EC, Ammerman S, Robinson TN, Killen JD.

Paediatr Drugs. 2012 Apr 1;14(2):91-108. doi: 10.2165/11594370-000000000-00000. Review.

3.

Adverse effects and tolerability of medications for the treatment of tobacco use and dependence.

Hays JT, Ebbert JO.

Drugs. 2010 Dec 24;70(18):2357-72. doi: 10.2165/11538190-000000000-00000. Review.

PMID:
21142259
4.

[Varenicline - pharmacological therapy of tobacco dependence].

Tschabitscher P, Homaier I, Lichtenschopf A, Groman E.

Wien Med Wochenschr. 2009;159(1-2):17-23. doi: 10.1007/s10354-008-0636-6. German.

PMID:
19225731
5.

Varenicline: a first-line treatment option for smoking cessation.

Garrison GD, Dugan SE.

Clin Ther. 2009 Mar;31(3):463-91. doi: 10.1016/j.clinthera.2009.03.021. Review.

PMID:
19393839
6.

Treating tobacco dependence in a medical setting.

Hurt RD, Ebbert JO, Hays JT, McFadden DD.

CA Cancer J Clin. 2009 Sep-Oct;59(5):314-26. doi: 10.3322/caac.20031. Epub 2009 Aug 25.

7.

Chronic sazetidine-A maintains anxiolytic effects and slower weight gain following chronic nicotine without maintaining increased density of nicotinic receptors in rodent brain.

Hussmann GP, DeDominicis KE, Turner JR, Yasuda RP, Klehm J, Forcelli PA, Xiao Y, Richardson JR, Sahibzada N, Wolfe BB, Lindstrom J, Blendy JA, Kellar KJ.

J Neurochem. 2014 May;129(4):721-31. doi: 10.1111/jnc.12653. Epub 2014 Feb 7.

8.

Pharmacological interventions for smoking cessation: an overview and network meta-analysis.

Cahill K, Stevens S, Perera R, Lancaster T.

Cochrane Database Syst Rev. 2013 May 31;(5):CD009329. doi: 10.1002/14651858.CD009329.pub2. Review.

PMID:
23728690
9.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2012 Apr 18;(4):CD006103. doi: 10.1002/14651858.CD006103.pub6. Review. Update in: Cochrane Database Syst Rev. 2016;(5):CD006103.

PMID:
22513936
10.

Counselors' knowledge of the adoption of tobacco cessation medications in substance abuse treatment programs.

Rothrauff TC, Eby LT.

Am J Addict. 2011 Jan-Feb;20(1):56-62. doi: 10.1111/j.1521-0391.2010.00095.x. Epub 2010 Nov 12.

11.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD006103.

PMID:
21328282
12.

Nicotine receptor partial agonists for smoking cessation.

Cahill K, Stead LF, Lancaster T.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD006103. doi: 10.1002/14651858.CD006103.pub4. Review. Update in: Cochrane Database Syst Rev. 2011;(2):CD006103.

PMID:
21154363
13.

Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation.

Keating GM, Lyseng-Williamson KA.

Pharmacoeconomics. 2010;28(3):231-54. doi: 10.2165/11204380-000000000-00000. Review.

PMID:
20108995
14.

Systematic review and meta-analysis of combination therapy for smoking cessation.

Shah SD, Wilken LA, Winkler SR, Lin SJ.

J Am Pharm Assoc (2003). 2008 Sep-Oct;48(5):659-65. doi: 10.1331/JAPhA.2008.07063. Review.

PMID:
18826906
15.

An internet survey of use, opinions and preferences for smoking cessation medications: nicotine, varenicline, and bupropion.

Etter JF, Schneider NG.

Nicotine Tob Res. 2013 Jan;15(1):59-68. doi: 10.1093/ntr/nts084. Epub 2012 Apr 22.

PMID:
22529220
16.

Smoking cessation pharmacotherapy--nicotine and non-nicotine preparations.

Frishman WH.

Prev Cardiol. 2007 Spring;10(2 Suppl 1):10-22. Review.

17.

Interventions to increase adherence to medications for tobacco dependence.

Hollands GJ, McDermott MS, Lindson-Hawley N, Vogt F, Farley A, Aveyard P.

Cochrane Database Syst Rev. 2015 Feb 23;(2):CD009164. doi: 10.1002/14651858.CD009164.pub2. Review.

PMID:
25914910
18.

[Current and future medical drugs for smoking cessation].

Kusma B, Mache S, Deissenrieder F, Quarcoo D, Welte T, Groneberg D.

Laryngorhinootologie. 2009 Jun;88(6):410-9; quiz 420-2. doi: 10.1055/s-0029-1220929. Epub 2009 Jun 5. German.

PMID:
19504411
19.

Emerging drugs for the treatment of tobacco dependence: 2014 update.

Elrashidi MY, Ebbert JO.

Expert Opin Emerg Drugs. 2014 Jun;19(2):243-60. doi: 10.1517/14728214.2014.899580. Epub 2014 Mar 22. Review.

PMID:
24654737
20.

Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt.

West R, Baker CL, Cappelleri JC, Bushmakin AG.

Psychopharmacology (Berl). 2008 Apr;197(3):371-7. Epub 2007 Dec 15.

PMID:
18084743

Supplemental Content

Support Center